Ginkgo Bioworks logo

Ginkgo Bioworks

Boston, MA

Ginkgo Bioworks is a biotech company from the United States founded in 2009 by scientists from MIT and headed by Tom Knight. The company specializes in using genetic engineering to produce bacteria with industrial applications. Ginkgo Bioworks is an analytics company that designs organisms for customers in a range of industries. It is the self-proclaimed "Organism Company" and is one of the world's largest privately held biotech companies. As of 2019, it was valued at $4.2 billion.

https://www.ginkgobioworks.com/

Company Details

Founded

2008

Employees

834 employees

Raised

$1,575,403,008

Headquarters Location

Boston, MA

Public

Yes

Acquired

No

CEO

Jason KellyJason Kelly

Founders

Barry Canton
Barry Canton
Jason Kelly
Jason Kelly
Tom Knight
Tom Knight
Austin Che
Austin Che
Reshma Shetty
Reshma Shetty

Company Collections

These are collections Ginkgo Bioworks is a part of. Click on the collection name to view similar companies.

Current Job Listings

Listing 0 of 11 job openings

    Ginkgo Bioworks Headquarters Location

    27 Drydock Avenue 8th Floor, Boston, MA 022102383

    Total Amount Raised: $1,575,403,008

    Ginkgo Bioworks' Investors

    Ginkgo Bioworks Funding Rounds

    • IPO

      Unknown

    • Post Ipo Equity

      $775,000,000

      Post Ipo Equity Investors

      Northern Star Partners
      Counterpoint
      ARK Investment Management
      T. Rowe Price
      ArrowMark Partners
      Casdin Capital
      Franklin Advisors
      Putnam Investments
      Viking Global Investors
      Cascade Investment
      Bain Capital Public Equity
      Baillie Gifford & Co
    • Series F

      $70,000,000

      Series F Investors

      General Atlantic
      Illumina
      Viking Global Investors
      Empede Capital
    • Series E

      $290,000,000

      Series E Investors

      Viking Global Investors
      Cascade Investment
      General Atlantic
      T. Rowe Price
      MEROS
    • Series D

      $275,000,000

      Series D Investors

      Bill Gates
      Cascade Investment
      Viking Global Investors
      Y Combinator
      General Atlantic
      bpd partners
    • Series C

      $100,000,000

      Series C Investors

      Senator Investment Group
      Cascade Investment
      Baillie Gifford & Co
      Viking Global Investors
      Allen & Company of Florida
      Y Combinator
    • Series B

      $53,328,100

      Series B Investors

      Viking Global Investors
      OS Fund
      Felicis Ventures
      11.2 Capital
      Vast Ventures
      Ken Arnold
      ID Ventures America
      MassVentures
      DCVC
      iGlobe Partners
      Y Combinator
    • Series A

      $9,000,000

      Series A Investors

      Felicis Ventures
      OS Fund
      DCVC
      iGlobe Partners
      Vast Ventures
    • Grant

      $179,999

      Grant Investors

      National Science Foundation
    • Seed

      $1,000,000

      Seed Investors

      Y Combinator
      TSVC
      Farzad Nazem
      David Spector
      11.2 Capital
      Todd Corenson
      Ken Cheng
      Ken Arnold
      Arda Kutsal
      Louis Beryl
      Jonathan Downey
      Vast Ventures
      Azure Capital Partners
      Felicis Ventures
    • Grant

      $400,000

      Grant Investors

      MassVentures
    • Grant

      $1,314,964

      Grant Investors

      National Science Foundation
    • Grant

      $180,000

      Grant Investors

      National Science Foundation
    Funding info provided by Diffbot.

    Ginkgo Bioworks Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ginkgo Bioworks.

    Recent reviews